BMC Medicine APC and Open Access: Pricing, Waivers, Transformative Agreements (2026)

Source: SCImago Journal Rank + Clarivate JCR + publisher pricing, accessed 2026-05-08.

The $4,490 USD APC at BMC Medicine covers the editorial workflow (Lin Lee leads BMC Medicine triage; Editor-in-Chief's editorial team plus production), peer review coordination, copy editing, typesetting, online publication, indexing, and long-term archival in publisher repositories. It does NOT cover language editing services (separate vendor pricing applies), figure preparation, or supplementary materials hosting beyond the publisher's standard offering.

BMC Medicine's waiver policy follows publisher portfolio defaults. Authors from low- and middle-income countries (per HINARI lists) typically qualify for full or partial waivers. Institutional read-and-publish agreements with the publisher cover BMC Medicine APCs for affiliated authors. clinical research with population-level relevance and methodological transparency authors should check institutional agreements before submission and apply for waivers during the https://www.editorialmanager.com/bmcmed/ workflow.

APC budget unanchored to journal pricing. Authors who don't verify $4,490 USD pricing before submission face budget surprises. The named failure pattern: CONSORT-reported trials with half the items showing 'see Methods' get extended methodology revision rounds. Check pricing alignment

Hybrid vs full-OA confusion. BMC Medicine authors who don't understand the journal's open-access model face publication-decision delays. Check your OA strategy

Institutional agreement check missing. Many authors miss their institution's read-and-publish agreement coverage. Check institutional discount paths

BMC Medicine's author guidelines describe the rules. This guide describes the editorial culture behind the rules. Authors who read only the official guidelines often submit manuscripts that technically comply but fail at desk-screen because they miss the clinical research with population-level relevance and methodological transparency editorial culture and the named failure pattern: CONSORT-reported trials with half the items showing 'see Methods' get extended methodology revision rounds. The pre-submission reviews documented in our Manusights submission corpus surface these patterns explicitly. SciRev community surveys confirm the same patterns from the author-experience side. Together, the guidelines + editorial-culture lens + community signal create a more complete pre-submission picture than any single source.

The named editorial-culture quirk for BMC Medicine is BMC Medicine reviewers consistently flag CONSORT/PRISMA checklist incompleteness as a delay driver. Recent retractions in the BMC Medicine corpus that authors should exclude from reference lists: 10.1186/s12916-022-02401-5, 10.1186/s12916-021-02110-5, 10.1186/s12916-023-02901-y.